Lacosamide Olpha 150 mg film-coated tablets EFG

Patient Information Leaflet

Introduction

Patient Information Leaflet

Lacosamida Olpha 50 mg film-coated tablets EFG

Lacosamida Olpha 100 mg film-coated tablets EFG

Lacosamida Olpha 150 mg film-coated tablets EFG

Lacosamida Olpha 200 mg film-coated tablets EFG

Read all of this leaflet carefully before you start taking this medicine, as it contains important information for you.

• Keep this leaflet as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only; do not pass it on to other people, even if they have the same symptoms as you, as it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Leaflet Contents

1. What Lacosamida Olpha is and what it is used for
2. What you need to know before taking Lacosamida Olpha
3. How to take Lacosamida Olpha
4. Possible side effects
5. How to store Lacosamida Olpha
6. Contents of the pack and other information

1. What Lacosamida Olpha is and what it is used for

What is Lacosamida

This medicine contains lacosamide, which belongs to a group of medicines called
"antiepileptic medicines". These medicines are used to treat epilepsy.

• You have been prescribed this medicine to reduce the number of seizures you experience.

What Lacosamida is used for

• Lacosamide is used:
  • alone or in combination with other antiepileptic medicines in adults, adolescents, and children from 2 years of age, to treat a certain type of epilepsy called "partial-onset seizures with or without secondary generalization". In this type of epilepsy, seizures affect only one side of the brain. However, they may then spread to larger areas on both sides of the brain;
  • in combination with other antiepileptic medicines in adults, adolescents, and children from 4 years of age, to treat primary generalized tonic-clonic seizures (generalized seizures, with loss of consciousness) in patients with idiopathic generalized epilepsy (a type of epilepsy believed to have a genetic origin).

2. What you need to know before starting to take Lacosamida Olpha

Do not take Lacosamida

• if you are allergic to lacosamide or to any of the other ingredients of this medicine

(listed in section 6). If you are unsure whether you are allergic, consult your doctor.

• if you have a heart rhythm problem called second- or third-degree AV block.

Do not take this medicine if either of the above applies to you. If you are unsure, consult your doctor or pharmacist before taking this medicine.

Warnings and precautions

Talk to your doctor before starting to use this medicine if:

• you have thoughts of self-harm or suicide. A small number of people being treated with antiepileptic medicines such as lacosamide have had thoughts of self-harm or suicide. If at any time you have such thoughts, contact your doctor immediately.

• you have a heart condition that affects your heartbeat and your pulse is often particularly slow, fast, or irregular (such as AV block, atrial fibrillation, or atrial flutter).

• you have severe heart disease such as heart failure or have had a myocardial infarction.

• you feel dizzy or fall frequently. Lacosamide may cause dizziness, which could increase the risk of accidental injury or falls. This means you should be cautious until you are accustomed to the effects of this medicine.

If any of the above apply to you (or you are unsure), consult your doctor or pharmacist before taking this medicine.

If you are taking this medicine, consult your doctor if you experience a new type of seizure or worsening of existing seizures.

If you are taking this medicine and experience symptoms of abnormal heartbeat (such as slow, fast, or irregular heartbeat, palpitations, dyspnea (difficulty breathing), dizziness, or fainting), contact your doctor immediately (see section 4).

Children

Lacosamide is not recommended for children under 2 years of age with epilepsy characterized by partial-onset seizures, or for children under 4 years of age with generalized tonic-clonic seizures. This is because it is not yet known whether it is effective and safe in children of these age groups.

Other medicines and lacosamide

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

In particular, inform your doctor or pharmacist if you are taking any of the following medicines that affect the heart. The reason is that lacosamide may also affect the heart.

• medicines used to treat heart problems.

• medicines that may increase the "PR interval" in a heart test (ECG or electrocardiogram), such as medicines for epilepsy or pain called carbamazepine, lamotrigine, or pregabalin.

• medicines used to treat certain types of arrhythmia or heart failure.

If any of the above apply to you (or you are unsure), speak with your doctor or pharmacist before taking this medicine.

Also inform your doctor or pharmacist if you are taking any of the following medicines. The reason is that they may also increase or decrease the effect of lacosamide in your body.

• antifungal medicines such as fluconazole, itraconazole, or ketoconazole.
• medicines for HIV such as ritonavir.
• medicines for bacterial infections such as clarithromycin or rifampicin.
• a herbal medicine used to treat mild anxiety and depression called St. John's wort.

If any of the above apply to you (or you are unsure), speak with your doctor or pharmacist before taking lacosamide.

Taking lacosamide with alcohol

As a precaution, do not take this medicine with alcohol.

Pregnancy and breastfeeding

Women of childbearing potential should discuss the use of contraception with their doctor.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Lacosamide is not recommended during pregnancy, as the effects of this medicine on pregnancy and the fetus are unknown.

Breastfeeding is not recommended while taking this medicine, as this medicine passes into breast milk. Seek immediate advice from your doctor if you are pregnant or planning to become pregnant. They will help you decide whether or not to take lacosamide.

Do not stop treatment without first talking to your doctor, as this could increase seizures. Worsening of your condition may also harm the fetus.

Driving and using machines

You must not drive, ride a bicycle, or operate any tools or machinery until you know how this medicine affects you. The reason is that lacosamide may cause dizziness or blurred vision.

3. How to take/use Lacosamida Olpha

Follow exactly the instructions for administering this medicine as given by your doctor or pharmacist. If in doubt, please consult your doctor or pharmacist again. Another formulation(s) of this medicine may be more suitable for children; please consult your doctor or pharmacist.

Taking Lacosamida

• Take lacosamida twice daily, approximately 12 hours apart.
• Try to take it at about the same time each day.
• Swallow the lacosamida tablet with a glass of water.
• You may take lacosamida with food or separately.

Normally, you will start with a low daily dose, and your doctor will gradually increase the dose over several weeks. Once you reach the dose that works well for you, known as the “maintenance dose”, you will take the same amount every day. Lacosamida is used as a long-term treatment. You must continue taking lacosamida until your doctor tells you to stop.

What dose to take

The recommended doses of lacosamida for different age and weight groups are listed below. Your doctor may prescribe a different dose if you have kidney or liver problems.

Adults, adolescents, and children weighing 50 kg or more

When taking lacosamida alone:

The usual starting dose is 50 mg twice daily.

Your doctor may also prescribe a starting dose of 100 mg of lacosamida twice daily. Your doctor may increase your twice-daily dose by 50 mg each week, until reaching a maintenance dose between 100 mg and 300 mg twice daily.

When taking lacosamida with other antiepileptic medicines:

The usual starting dose is 50 mg twice daily.

Your doctor may increase your twice-daily dose by 50 mg each week, until reaching a maintenance dose between 100 mg and 200 mg twice daily.

If you weigh 50 kg or more, your doctor may start lacosamida treatment with a single “loading dose” of 200 mg. You would then begin taking the regular maintenance dose 12 hours later.

Children and adolescents weighing less than 50 kg

• In the treatment of partial-onset seizures: note that this medicine is not recommended for children under 2 years of age.
• In the treatment of primary generalized tonic-clonic seizures: note that this medicine is not recommended for children under 4 years of age.

The dose depends on body weight. Treatment is usually started with the oral syrup, and only switched to tablets if the patient is able to swallow them and can achieve the correct dose using tablets of different strengths. Your doctor will prescribe the pharmaceutical form best suited to you.

If you take more lacosamida than you should

If you have taken more lacosamida than prescribed, contact your doctor immediately. Do not attempt to drive.

You may experience:

• dizziness;
• feeling sick (nausea) or being sick (vomiting);
• seizures (fits), heart rhythm problems such as slow, fast or irregular pulse, coma, or low blood pressure with tachycardia and sweating.

In case of overdose or accidental ingestion, contact your doctor, pharmacist, or call the Toxicology Information Service immediately at: 91 562 04 20, stating the medicine and the amount ingested.

If you forget to take lacosamida

• If you forget a dose within 6 hours of the scheduled time, take it as soon as you remember.

• If you forget a dose more than 6 hours after the scheduled time, do not take the missed dose; instead, take lacosamida at the next scheduled time.

• Do not take a double dose to make up for a missed dose.

If you stop taking lacosamida

• Do not stop taking lacosamida without telling your doctor, as epilepsy may return or worsen.
• If your doctor decides to discontinue your lacosamida treatment, you will be given instructions on how to gradually reduce the dose.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, lacosamide may cause adverse effects, although not everyone experiences them.

Nervous system effects such as dizziness may be greater after a single "loading" dose.

Inform your doctor or pharmacist if you experience any of the following effects:

Very common: may affect more than 1 in 10 patients

• Headache;
• Feeling dizzy or sick (nausea);
• Double vision (diplopia).

Common: may affect up to 1 in 10 patients

• Brief jerks of a muscle or group of muscles (myoclonic seizures);
• Difficulty coordinating movements or walking;
• Problems maintaining balance, agitation (tremor), tingling (paresthesia), or muscle spasms, falling easily and bruising;
• Memory problems, thinking difficulties or trouble finding words, confusion;
• Rapid, uncontrolled eye movements (nystagmus), blurred vision;
• Sensation of dizziness (vertigo), feeling of drunkenness;
• Feeling dizzy (vomiting), dry mouth, constipation, indigestion, excessive gas in the stomach or intestines, diarrhea;
• Reduced sensitivity, difficulty articulating words, attention disturbance;
• Ringing in the ears such as buzzing, ringing, or hissing sounds;
• Irritability, sleep problems, depression;
• Drowsiness, tiredness or weakness (asthenia);
• Itching, rash.

Uncommon: may affect up to 1 in 100 patients

• Decreased heart rate, palpitations, irregular pulse, or other changes in the heart's electrical activity (conduction disorder);
• Exaggerated sense of well-being, seeing and/or hearing things that are not real;
• Allergic reaction to the medicine, hives;
• Blood tests may show abnormalities in liver function tests, liver damage;
• Thoughts of self-harm or suicide, or suicide attempt: inform your doctor immediately;
• Feeling angry or agitated;
• Abnormal thoughts or loss of sense of reality;
• Severe allergic reactions causing swelling of the face, throat, hands, feet, ankles, or lower legs;
• Fainting;
• Abnormal involuntary movements (dyskinesia).

Frequency not known: cannot be estimated from available data

• Abnormally fast heartbeat (ventricular tachyarrhythmia);
• Sore throat, high temperature, and increased frequency of infections. Blood tests may show a severe decrease in a specific type of white blood cells (agranulocytosis);
• Serious skin reaction, which may include high temperature and other flu-like symptoms, facial rash, widespread rash with swollen lymph nodes (enlarged lymph nodes). Blood tests may show increased liver enzyme levels and an increase in a type of white blood cells (eosinophilia);
• Widespread rash with blisters and peeling of the skin, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome), and a more severe form causing skin peeling over more than 30% of the body surface (toxic epidermal necrolysis);
• Seizures.

Other adverse effects in children

Additional adverse effects observed in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), eating less than usual (decreased appetite), behavioral changes, not acting as they normally do (abnormal behavior), and lack of energy (lethargy). Drowsiness (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. They can also be reported directly via the Spanish Pharmacovigilance System for Human Medicines website: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Lacosamide Olpha

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton and blister after EXP/CAD. The expiry date is the last day of the month indicated.

Do not store above 30°C.

Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their packaging at the SIGRE collection point at your pharmacy. If you are in doubt, ask your pharmacist how to dispose of medicines and packaging you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Lacosamide Olpha

• The active substance is lacosamide.

Each Lacosamide Olpha 50 mg tablet contains 50 mg of lacosamide.

Each Lacosamide Olpha 100 mg tablet contains 100 mg of lacosamide.

Each Lacosamide Olpha 150 mg tablet contains 150 mg of lacosamide.

Each Lacosamide Olpha 200 mg tablet contains 200 mg of lacosamide.

• The other components are:

Tablet core: microcrystalline cellulose (101), microcrystalline cellulose (102), crospovidone type A, colloidal silicon dioxide, hydroxypropylcellulose (low substituted), hydroxypropylcellulose, magnesium stearate.

Coating:

50 mg:

hypromellose 6 mPas (E464), hypromellose 15 mPas (E464), titanium dioxide (E171), talc (E553b), polyvinyl alcohol (E1203), polyethylene glycol 3350 (E1521), lecithin (E322), red iron oxide (E172), black iron oxide (E172)

100 mg:

hypromellose 6 mPas (E464), hypromellose 15 mPas (E464), titanium dioxide (E171), talc (E553b), polyvinyl alcohol (E1203), polyethylene glycol 3350 (E1521), lecithin (E322), yellow iron oxide (E172)

150 mg:

hypromellose 6 mPas (E464), hypromellose 15 mPas (E464), titanium dioxide (E171), talc (E553b), polyvinyl alcohol (E1203), polyethylene glycol 3350 (E1521), lecithin (E322), red iron oxide (E172), yellow iron oxide (E172), black iron oxide (E172)

200 mg:

hypromellose 6 mPas (E464), hypromellose 15 mPas (E464), titanium dioxide (E171), talc (E553b), polyvinyl alcohol (E1203), polyethylene glycol 3350 (E1521), lecithin (E322), indigo carmine aluminium lake (E132)

Appearance of the product and contents of the pack

• Lacosamide Olpha 50 mg are pink, oval-shaped, film-coated tablets, biconvex, marked with “L50” on one side and smooth on the other.

• Lacosamide Olpha 100 mg are yellow, oval-shaped, film-coated tablets, biconvex, marked with “L100” on one side and smooth on the other.

• Lacosamide Olpha 150 mg are salmon-coloured, oval-shaped, film-coated tablets, biconvex, marked with “L150” on one side and smooth on the other.

• Lacosamide Olpha 200 mg are blue, oval-shaped, film-coated tablets, biconvex, marked with “L200” on one side and smooth on the other.

Lacosamide Olpha is available in packs of 14, 28, 56, 98 and 168 film-coated tablets in aluminium blisters.

Only certain pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Olpha AS,
Rupnicu iela 5,
Olaine, Olaines novads, LV-2114,
Latvia

Manufacturer

Macleods Pharma UK Limited,
Wynyard Park House,
Wynyard Avenue,
Wynyard, Billingham,
TS22 5TB,
United Kingdom

Synoptis Industrial Sp. z o.o
ul. Rabowicka 15, 62-020
Swarzedz, Poland

Date of the most recent revision of this summary:

Detailed information on this medicine is available on the website of the Spanish Agency of Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)